Now what I think is the best part of this new alliance is not the power of David and Barb Pitcock, which I feel are two fantastic servant leaders. but it is the combined power of Dr. Joel Wallech and Dr. Dennis Harris.
Click Listen to David Pitcock
Click here to listen to Barb Pitcock
Dr. Joel Wallach
A biomedical research pioneer, Dr. Joel D. Wallach, DVM, ND spent more than 40 years in the field of Veterinary Medicine, observing and researching the effects of individual nutrients on animal health, before becoming a Naturopathic Physician in 1982. Today, Dr. Wallach is renowned for his groundbreaking research on the health benefits of selenium and other minerals. He currently dedicates his time to lecturing throughout the world on the therapeutic benefits of vitamins and minerals, and on lobbying the U.S. Food and Drug Administration on behalf of the dietary supplement industry.
As a researcher at the Emory University Yerkes National Primate Center in Atlanta, Georgia in 1977, Dr. Wallach discovered the world’s first known case of non-human cystic fibrosis in a selenium-deficient Rhesus monkey. At the time, cystic fibrosis was believed to the result of a human genetic disorder. Dr. Wallach’s monumental discovery set him on a 20-year path of research on the health benefits of selenium and other minerals. As a result of this work, he became known as The Mineral Doctor and the Father of Liquid Mineral Supplementation.
Dr. Wallach currently dedicates his time to lecturing throughout the world on the therapeutic benefits of vitamins and minerals, and on lobbying the U.S. Food and Drug Administration on behalf of the dietary supplement industry. His tireless efforts and dedication to the public’s First Amendment rights to complete information on the therapeutic benefits of nutrition prompted the FDA to establish Qualified Health Claims for Selenium (“may reduce the risk of certain cancers”) and Omega-3 Essential Fatty Acids (“may reduce the risk of coronary heart disease”). Only a few Qualified Health Claims exist, placing Youngevity in a unique position among Dietary Supplement and Direct Marketing companies.
Dr. Dennis Harris
Dr. Harris graduated from Ohio State University Medical School in 1963 and completed his internship at Grant Hospital, a University affiliated hospital in Columbus, Ohio in 1964. He then entered a residency training program, specializing in Physical Medicine and Rehabilitation at Ohio State University. Upon completion, he moved to Dallas, Texas in 1966 to become chief resident in a Physical Medicine residency training program at Parkland Hospital, Southwestern Medical School, University of Texas. He completed the last year of his residency training in 1967 and moved to Scottsdale, Arizona to begin private practice.
In 1968, Dr. Harris established the Department of Physical Medicine and Rehabilitation at Scottsdale Memorial Hospital in Scottsdale, Arizona and was appointed director of that department which he operated until 1984. Dr. Harris then established the Southwest Pain Control Program and directed that program through 1974. This program was the first chronic pain control program in the Southwest, the eighth program in the country, and the first program to be performed on only an outpatient basis. After the efficacy of the program was well established, the entire program was moved to Mesa Lutheran Hospital in 1974 at the hospital’s request. The hospital appointed Dr. Harris as director of that program, and he maintained this position through 1983.
In spite of being trained in traditional medicine, Dr. Harris observed patient after patient experiencing severe, and sometimes life-threatening, side effects from medications. Believing that there was a safer, better and healthier way to practice medicine, Dr. Harris began reading, attending courses and going to lectures and seminars to learn about nutrition and natural health products. This opened up an entirely new world for Dr. Harris, and he developed a new passion—treating the whole patient instead of just symptoms…doing it safely and effectively with natural health products…and helping his patients achieve the best quality of life. Dr. Harris strongly believes that everything we do should be directed toward improving our quality of life.
In 1993, Dr. Harris created and began clinically testing a natural oral remedy to eliminate snoring. This product eventually became No More SNORzzz. In 1994, after clarifying the link between snoring, allergies, sinusitis and asthmatic bronchitis, Dr. Harris created and began testing a natural formulation for relief for allergy and sinus symptoms. 83% good to excellent test results were obtained. This product eventually became BREATHese.
Dr. Harris’ major passion in medicine has been the non-surgical diagnosis and treatment of pain. This propelled Dr. Harris into active research and development wherein, during the past twelve years, he has created an entire line of natural, safe, effective and unique products. His most recent efforts have been devoted to the formulation of products in four areas:
1. Pain—in which he draws from his 30+ years of knowledge and experience.
2. Diabetes—a major problem so extensive that it has the potential to bankrupt national health care systems.
3. Weight Management—a condition so common that it affects 2/3 of Americans.
4. Anti-aging—utilizing the latest scientific research to “turn back the clock” and prevent or retard the diseases commonly
To date, Dr. Harris has been granted three US patents—No More Snorzzz, BREATHEese, and GlucoLiv. The pain products are currently under patent pending status.
Deal Announced at Livinity’s Annual Convention Held July 13-14 in Kansas City, MO
SAN DIEGO–(BUSINESS WIRE)–Growing direct-selling conglomerate Youngevity® Essential Life Sciences (www.Youngevity.com) announces that it has entered into a sales and marketing alliance with Livinity™, Inc. (www.Livinity.com), a Russell, Kansas-based direct seller of health and wellness products. The alliance will integrate Livinity’s established product line along with its 10,000 distributors and customers. Youngevity is a wholly-owned subsidiary of AL International (PINKSHEETS: JCOF) (www.alintjcof.com), a global marketer of lifestyle and nutritional products and gourmet fortified coffee.
Livinity is a direct-selling health and wellness company with a strong focus on pain management, stress relief and energy. Founded in 1996 by David Pitcock and Barb Pitcock, the company is dedicated to empowering its distributors and customers via a wide variety of personal care products as well as nutritional supplements. Livinity’s key product lines include Stress-ESE Plus, Livinity RELIEF Pain Gel & Capsules, and BlueREZ Healthy Energy Shots. As a result of the agreement, distributors and customers from both Livinity and Youngevity will have access to both of their products and
The agreement with Youngevity was announced at Livinity’s annual convention with over 500 attendees, “Livinity’s Leap to the Future,” held July 13-14 at the Holiday Inn KCI Airport Expo Center in Kansas City, Missouri. To make the announcement, Dr. Joel Wallach, cofounder of Youngevity, was joined on stage by company executives including Bill Andreoli, President; Dr. Dennis H. Harris, medical director of Livinity; and the Pitcocks.
“This agreement is the latest step in Youngevity’s long-term growth strategy of bringing superior health and wellness products to our distribution base,” commented Steve Wallach, CEO of AL International. “We are delighted that Livinity has agreed to join the Youngevity family, given the obvious synergies between our two companies. The Pitcocks share our vision for growth and will be a strong addition to our team with their impressive 15-year track record of building successful direct selling companies. We are confident that our synergies will drive growth and we look forward to expanding our distribution.”
“The range of Youngevity’s products and the strength of their distribution infrastructure is a natural complement to our product line,” commented David Pitcock, President and CEO of Livinity. “We are dedicated to maintaining a strong focus on leveraging the influence of our direct selling experience, while simultaneously enjoying the benefits of a partnership with Youngevity’s growing business.”
About Youngevity® Essential Life Sciences
Youngevity Essential Life Sciences (www.Youngevity.com), headquartered in San Diego, CA, is a nutrition and lifestyle-related
services company dedicated to promoting vibrant health and flourishing economics. Founded in 1997 by Drs. Joel Wallach, DVM, ND, and Ma Lan, MD, as AL Global, Inc., the company adopted the name Youngevity in 2006. Youngevity is the only network marketing company to have a qualified FDA Health Claim. Dr. Wallach’s work has been published in more than 70 peer-reviewed and referenced scientific journals and books.
About AL International
AL International, Inc. (PINKSHEETS: JCOF) (www.alintjcof.com) is a fast-growing, innovative, multi-dimensional company that offers a wide range of consumer products and
services, primarily through person-to-person selling relationships that comprise a “network of networks.” The company also is a vertically integrated producer of the finest coffees for the commercial, retail and direct sales channels. AL International was formed after the merger of Youngevity Essential Life Sciences (www.Youngevity.com) and Javalution Coffee Company in the summer of 2011.
Safe Harbor Statement
This release includes forward-looking statements on our current expectations and projections about future events. In some cases forward-looking statements can be identified by terminology such as “may,” “should,” “potential,” “continue,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” and similar expressions. These statements are based upon current beliefs, expectations and assumptions and are subject to a number of risks and uncertainties, many of which are difficult to predict and include statements relating to our business plan and growth strategy through acquisition. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from those reflected in our forward-looking statements include, among others, the ability to implement our business plan and growth strategy through acquisition and the continued growth of our distributor base. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release based on new information, future events, or otherwise, except as required by law.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.